Infant immunity, though fleeting, found to be strong

May 28, 2014 by Carly Hodes, Cornell University
Infant immunity, though fleeting, found to be strong
Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID

(Medical Xpress)—"Forgetful" immune systems leave infants particularly prone to infections, claims a new Cornell study. Upending the common theory that weak immune cells are to blame, the study has found that infants' immune systems in mice actually respond to infection with more speed and strength than adults. Yet the immunities they create fail to last.

Published in the Journal of Immunology in May, the discovery suggests a new angle immunizations could take to better protect infants and children from infectious diseases.

Infectious disease accounts for more than one-third of infant deaths worldwide, according to the World Health Organization. Immunizations protect people by "teaching" immune systems to remember pathogens. But infant immunities rapidly wane, often requiring extra booster shots after an initial vaccination.

"The perfect vaccine would be a single dose given at birth that generates long-lasting immunity," said immunologist Brian Rudd at the College of Veterinary Medicine, the study's lead author. "No such vaccine exists because we haven't understood why infants rapidly lose immunities. Our finding could change the way we immunize infants and ultimately lead to more effective ways of enhancing immunity in early life."

Immunity against most microbes depends on forming memory T cells that remember specific pathogens and can rapidly respond to future infections. Adults almost always generate large numbers of effective memory T cells during infection, around 10 percent of which stay in a long-lived memory pool to rapidly respond next time.

Rudd found that newborn T cells generated in response to infection met dramatically different fates. When met with the same pathogen, newborn immune systems in mice made T cells that responded more rapidly to infection than adult cells, but quickly became terminally differentiated, never making it into the memory pool. This disproves the common theory that newborn have a weak or suboptimal response to infection.

"Surprisingly, we found that newborns' cells actually responded more vigorously to infection compared to adults," said Rudd, assistant professor of immunology. "We also found that newborns' cells go through their lifespans more quickly and die off sooner, before they can give rise to memory T cells and remember what they've learned. So the is forced to start the learning process over again when infected by the same pathogen later in life."

Rudd's lab is adjusting the expression of different proteins in different-aged T cells to determine how developmental variation in these factors influences memory cell behavior and fate. The researchers are also performing genomewide analyses of different-aged T cells to find the genes that code these differences.

"We hope to find a way to make neonatal behave more like in how they learn from vaccines and respond to infection," said Rudd. "Knowledge gained from these studies could be used to design more effective therapeutic interventions and vaccines that can be safely administered in early life."

Explore further: What makes the newborn immune system in the lungs different and vulnerable?

Related Stories

What makes the newborn immune system in the lungs different and vulnerable?

February 13, 2014
Newborns are more susceptible to infections, presumably because of their immature and inexperienced immune systems. The most common dangerous condition in newborns and infants are lower respiratory tract infections caused ...

'Bystander' chronic infections thwart development of immune cell memory

May 15, 2014
Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines ...

Study uncovers new explanation for infection susceptibility in newborns

November 6, 2013
Cells that allow helpful bacteria to safely colonize the intestines of newborn infants also suppress their immune systems to make them more vulnerable to infections, according to new research in Nature.

Early activation of immune response could lead to better vaccines

August 30, 2012
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a new "first response" mechanism that the immune system uses to respond to infection. The findings challenge the current understanding ...

Researchers find new method to combat common childhood illness

April 18, 2014
Almost all children are infected with respiratory syncytial virus by the time they are two. Most recover quickly from cold-like symptoms. But for others, RSV can cause serious lung infections, such as bronchiolitis and pneumonia, ...

Study: Understanding immunity as we age

January 13, 2014
(Medical Xpress)—Researchers at the University of Arizona College of Medicine – Tucson have found a key to understanding the aging immune system's decreased response to infectious diseases, which remain among the leading ...

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.